Atai life sciences reports third quarter 2023 financial results and pipeline highlights

New york and berlin, nov. 14, 2023 (globe newswire) -- atai life sciences (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, reported third quarter 2023 financial results and provided corporate updates.
ATAI Ratings Summary
ATAI Quant Ranking